PPH (VanEck Pharmaceutical ETF) Stock Analysis - AI Report

VanEck Pharmaceutical ETF (PPH) is a publicly traded the market company. As of May 21, 2026, PPH trades at $102.63 with a market cap of $0 and a P/E ratio of 0.00. PPH moved +0.16% today. Year to date, PPH is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces PPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on PPH?

Rallies AI research for PPH combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

PPH Key Metrics

Key financial metrics for PPH
MetricValue
Price$102.63
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume125.21K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest PPH News

PPH Analyst Consensus

PPH analyst coverage data. Average price target: $0.00.

Common questions about PPH

What is the AI research view on PPH?
Rallies AI research for PPH combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for PPH?
Rallies AI research for PPH combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is PPH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PPH. It does not provide personalized investment advice.
PPH

PPH